See All Slides - tctmd.com

Slides

Presentation TCT 2014

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

Presenter: John Ormiston

September 16, 2014

Presentation TCT 2014

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Presenter: Marius Hornung

September 16, 2014

Presentation TCT 2014

Diamondback 360 Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions in Elderly Patients: 1-Year Results from the ORBIT II Trial

Presenter: Arthur Lee

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Presenter: Deepak Bhatt

September 16, 2014

Presentation TCT 2014

Comparison of sirolimus-eluting stents with biodegradable polymer versus zotarolimus-eluting stents with durable polymer assessed by optical coherence tomography: The ALSTER-OCT___

Presenter: Christian Heeger

September 16, 2014

Presentation TCT 2014

The Genetic Basis Of Patent Foramen Ovale

Presenter: Nabil Noureddin

September 16, 2014

Presentation TCT 2014

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Presenter: Christopher Meduri

September 16, 2014

Presentation TCT 2014

Predictors and Implications of Subintimal Tracking During Endovascular Revascularization of Chronic Total Occlusions in the Infrainguinal Arteries

Presenter: Atif Mohammad

September 16, 2014

Presentation TCT 2014

Carotid Artery Stenting In Patients With Contra-lateral Stenosis Or Occlusion_ A Single Center Experience Of More Than 1100 Cases

Presenter: J?rgen Kammler

September 16, 2014

Advertisement

Slides

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Diamondback 360 Coronary Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions in Elderly Patients: 1-Year Results from the ORBIT II Trial

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Comparison of sirolimus-eluting stents with biodegradable polymer versus zotarolimus-eluting stents with durable polymer assessed by optical coherence tomography: The ALSTER-OCT___

The Genetic Basis Of Patent Foramen Ovale

The Cost of TAVR: Association Between Length of Stay and the Cost of Transfemoral Transcatheter Aortic Valve Replacement in Medicare Patients

Predictors and Implications of Subintimal Tracking During Endovascular Revascularization of Chronic Total Occlusions in the Infrainguinal Arteries

Carotid Artery Stenting In Patients With Contra-lateral Stenosis Or Occlusion_ A Single Center Experience Of More Than 1100 Cases

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content